MicroRNA profiling for early detection of nonmelanoma skin cancer

Clinical and Experimental Dermatology

Volumn 41, Issue 4, 2016, Pages 346-351

  Balci, S ^a   Ayaz, L ^b   Gorur, A ^a   Yildirim Yaroglu, H ^c   Akbayir, S ^a   Dogruer Unal, N ^a   Bulut, B ^a   Tursen, U ^a   Tamer, L ^a  

^a MERSIN UNIVERSITY   (Turkey)

^b TRAKYA UNIVERSITY   (Turkey)

^c TOROS UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 145 5P; MICRORNA 186 5P; MICRORNA 19A 3P; MICRORNA 25 3P; MICRORNA 30A 5P; MICRORNA 30E 30P; MICRORNA 451; MICRORNA 576 3P; MICRORNA 875 5P; UNCLASSIFIED DRUG; TUMOR MARKER;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EARLY CANCER DIAGNOSIS; FEMALE; GENE EXPRESSION PROFILING; HIGH THROUGHPUT SCREENING; HUMAN; MALE; MIDDLE AGED; NON MELANOMA SKIN CANCER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; BLOOD; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; PROCEDURES; SKIN TUMOR;

BIOMARKERS, TUMOR; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; EARLY DETECTION OF CANCER; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MICRORNAS; MIDDLE AGED; SKIN NEOPLASMS;

EID: 84940056343     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/ced.12736     Document Type: Article

References (24)

1. Philippidou D, Schmitt M, Moser D, et al,. Signatures of microRNAs and selected microRNA Target genes in human melanoma. Cancer Res 2010; 70: 4163-73.
2. Tung R, Vidimos A,. Non-melanoma skin cancer. Available at: http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/dermatology/nonmelanoma-skin-cancer/ (accessed 12 March 2015).
3. Filipowicz W, Bhattacharyya SN, Sonenberg N,. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 2008; 9: 102-14.
4. Guo H, Ingolia NT, Weissman JS, et al,. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010; 466: 835-40.
5. Alvarez-Garcia I, Miska EA,. MicroRNA functions in animal development and human disease. Development 2005; 132: 4653-62.
6. Sand M, Skrygan M, Georgas D, et al,. Expression levels of the microRNA maturing microprocessor complex component DGCR8 and the RNA-induced silencing complex (RISC) components Argonaute-1, Argonaute-2, PACT, TARBP1, and TARBP2 in epithelial skin cancer. Mol Carcinog 2012; 51: 916-22.
7. Sand M, Gambichler T, Skrygan M, et al,. Expression levels of the microRNA processing enzymes Drosha and dicer in epithelial skin cancer. Cancer Invest 2010; 28: 649-53.
8. Sand M, Skrygan M, Georgas D, et al,. Microarray analysis of microRNA expression in cSCC. J Dermatol Sci 2012; 68: 119-26.
9. Kimura S, Naganuma S, Susuki D, et al,. Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC. Oncol Rep 2010; 23: 1625-33.
10. Xu X, Chen Z, Zhao X, Wang J, Ding D, Wang Z, Tan F, Tan X, Zhou F, Sun J, Sun N, Gao Y, Shao K, Li N, Qiu B, He J, et al,. MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma. Biochem Biophys Res Comm 2012; 421: 640-5.
11. Wu C1, Li M, Hu C, Duan H,. Clinical significance of serum miR-223, miR-25 and miR-375 in patients with esophageal squamous cell carcinoma. Mol Biol Rep 2014; 41: 1257-66.
12. Xu JY, Yang LL, Ma C, et al,. MiR-25-3p attenuates the proliferation of tongue squamous cell carcinoma cell line Tca8113. Asian Pac J Trop Biomed 2013; 000: 412-20.
13. He L, Thomson JM, Hemann MT, et al,. A microRNA polycistron as a potential human oncogene. Nature 2005; 435: 828-33.
14. Uziel T, Karginov FV, Xie S, et al,. The miR-17-92 cluster collaborates with the Sonic Hedgehog pathway in medullablastoma. Proc Natl Acad Sci 2009; 106: 2812-17.
15. Zhu H, Wu H, Liu X, et al,. Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells. Biochem Pharmacol 2008; 76: 582-8.
16. Ries J, Vairaktaris E, Agaimy A, et al,. miR-186, miR-3651 and miR-494: potential biomarkers for oral squamous cell carcinoma extracted from whole blood. Oncol Rep 2014; 31: 1429-36.
17. Zhou L, Qi X, Potashkin JA, et al,. MicroRNAs miR-186 and miR-150 Down-regulate expression of the pro-apoptotic purinergic P2X7 receptor by activation of instability sites at the 3-untranslated region of the gene that decrease steady-state levels of the transcript. J Biol Chem 2008; 283: 28274-86.
18. Zhao H, Ding Y, Tie B, et al,. miRNA expression pattern associated with prognosis in elderly patients with advanced OPSC and OCC. Int J Oncol 2013; 43: 839-49.
19. Noguchi S, Mori T, Hoshino Y, et al,. Comparative study of anti-oncogenic microRNA-145 in canine and human malignant melanoma. J Vet Med Sci 2012; 74: 1-8.
20. Kano M, Seki N, Kikkawa N, et al,. miR-145, miR-133a and miR-133b: tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer 2010; 127: 2804-14.
21. Sand M, Skrygan M, Sand D,. Expression of microRNAs in basal cell carcinoma. Br J Dermatol 2012; 167: 847-55.
22. Wang F, Xia J, Wang N, Zong H,. miR-145 inhibits proliferation and invasion of esophageal squamous cell carcinoma in part by targeting c-Myc. Onkologie 2013; 36: 754-8.
23. Epstein EH,. Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer 2008; 8: 743-54.
24. Paroo Z, Ye X, Chen S, et al,. Phosphorylation of the human microRNA-generating complex mediates MAPK/Erk signaling. Cell 2009; 139: 112-22.